A number of organofluorine-containing drugs for prevention and treatment of cardiovascular disease have been launched worldwide over the past 50 years, with 40% of them being approved in the last decade; they belong to the categories of cholesterol-lowering agents (especially statins), antiarrhythmics, calcium-channel blockers for treating high blood pressure and chest pain (angina), thiazide diuretics used in treating hypertension and congestive heart failure, and antiplatelet agents for use in post-heart attack and valve replacement.
Organofluorine-containing therapeutics for treatment of cardiovascular disease
DE CANDIA, MODESTO
Writing – Original Draft Preparation
;ALTOMARE, Cosimo DamianoSupervision
2015-01-01
Abstract
A number of organofluorine-containing drugs for prevention and treatment of cardiovascular disease have been launched worldwide over the past 50 years, with 40% of them being approved in the last decade; they belong to the categories of cholesterol-lowering agents (especially statins), antiarrhythmics, calcium-channel blockers for treating high blood pressure and chest pain (angina), thiazide diuretics used in treating hypertension and congestive heart failure, and antiplatelet agents for use in post-heart attack and valve replacement.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
fluoro-dervs cvd.pdf
non disponibili
Tipologia:
Documento in Post-print
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
7.22 MB
Formato
Adobe PDF
|
7.22 MB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
